Cooper Companies Inc (NYSE:COO) has been given a consensus rating of “Buy” by the thirteen analysts that are presently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell rating, one has issued a hold rating and eleven have given a buy rating to the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is $318.91.

COO has been the subject of several research analyst reports. Zacks Investment Research cut Home Bancshares from a “hold” rating to a “sell” rating in a research report on Friday, June 7th. Wells Fargo & Co reissued a “buy” rating on shares of Allergan in a research report on Monday, June 10th. Raymond James reissued a “buy” rating and set a $26.00 price objective on shares of Propetro in a research report on Tuesday, July 2nd. Finally, Northcoast Research restated a “buy” rating and set a $340.00 price target (up from $331.00) on shares of Cooper Companies in a research note on Monday, June 3rd.

In other news, COO Daniel G. Mcbride sold 11,981 shares of the company’s stock in a transaction that occurred on Thursday, June 6th. The stock was sold at an average price of $315.99, for a total value of $3,785,876.19. Following the sale, the chief operating officer now directly owns 42,668 shares in the company, valued at approximately $13,482,661.32. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Michael Kalkstein sold 3,500 shares of the company’s stock in a transaction that occurred on Thursday, June 6th. The shares were sold at an average price of $316.28, for a total value of $1,106,980.00. The disclosure for this sale can be found here. Insiders have sold 77,678 shares of company stock worth $25,063,536 over the last 90 days. Corporate insiders own 1.70% of the company’s stock.

Hedge funds have recently added to or reduced their stakes in the company. Comerica Securities Inc. grew its holdings in shares of Cooper Companies by 5.6% during the fourth quarter. Comerica Securities Inc. now owns 903 shares of the medical device company’s stock valued at $230,000 after buying an additional 48 shares in the last quarter. LPL Financial LLC grew its holdings in shares of Cooper Companies by 17.9% during the fourth quarter. LPL Financial LLC now owns 3,737 shares of the medical device company’s stock valued at $951,000 after buying an additional 568 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. grew its stake in Cooper Companies by 3.8% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 2,123 shares of the medical device company’s stock valued at $540,000 after purchasing an additional 78 shares in the last quarter. Raymond James Financial Services Advisors Inc. grew its stake in Cooper Companies by 13.8% in the fourth quarter. Raymond James Financial Services Advisors Inc. now owns 1,782 shares of the medical device company’s stock valued at $454,000 after purchasing an additional 216 shares in the last quarter. Finally, BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp grew its stake in Cooper Companies by 14.8% in the fourth quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 12,378 shares of the medical device company’s stock valued at $3,150,000 after purchasing an additional 1,595 shares in the last quarter. Institutional investors own 96.56% of the company’s stock.

Shares of NYSE COO traded up $1.13 during trading hours on Friday, hitting $332.49. 2,627 shares of the company’s stock were exchanged, compared to its average volume of 295,179. Cooper Companies has a 1-year low of $228.65 and a 1-year high of $343.33. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.21 and a quick ratio of 0.68. The stock has a market cap of $16.24 billion, a PE ratio of 28.90, a price-to-earnings-growth ratio of 2.49 and a beta of 0.84. The firm has a 50-day moving average of $324.19.

Cooper Companies (NYSE:COO) last posted its quarterly earnings data on Thursday, May 30th. The medical device company reported $2.94 earnings per share for the quarter, topping the consensus estimate of $2.76 by $0.18. Cooper Companies had a return on equity of 17.25% and a net margin of 16.46%. The business had revenue of $654.30 million during the quarter, compared to analysts’ expectations of $655.00 million. During the same quarter in the previous year, the firm earned $2.86 EPS. The firm’s revenue was up 3.6% compared to the same quarter last year. On average, research analysts predict that Cooper Companies will post 12.27 earnings per share for the current year.

The company also recently declared a Semi-Annual dividend, which will be paid on Wednesday, August 7th. Investors of record on Tuesday, July 23rd will be paid a dividend of $0.03 per share. The ex-dividend date is Monday, July 22nd. Cooper Companies’s dividend payout ratio is 0.52%.

Cooper Companies Company Profile

The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.

See Also: What is systematic risk?

Analyst Recommendations for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.